Sarcolemmal cardiac K ATP channels as a target for the cardioprotective effects of the fluorine-containing pinacidil analogue, flocalin

British Journal of Pharmacology

Volumn 162, Issue 3, 2011, Pages 701-711

  Voitychuk, Oleg I ^a   Strutynskyi, Ruslan B ^b   Yagupolskii, Lev M ^c   Tinker, Andrew ^d   Moibenko, Olexiy O ^b   Shuba, Yaroslav M ^a,b  

^a INSTITUTE OF HYDROBIOLOGY   (Ukraine)

^b BOGOMOLETZ INSTITUTE OF PHYSIOLOGY   (Ukraine)

^c INSTITUTE OF ORGANIC CHEMISTRY   (Ukraine)

^d UNIVERSITY COLLEGE LONDON   (United Kingdom)

Author keywords

cardiac excitability cardioprotection; flocalin; KATP channel; KATP channel openers

Indexed keywords

ADENOSINE TRIPHOSPHATE SENSITIVE POTASSIUM CHANNEL; FLOCALIN; INWARDLY RECTIFYING POTASSIUM CHANNEL SUBUNIT KIR6.2; POTASSIUM CHANNEL STIMULATING AGENT; SULFONYLUREA RECEPTOR; SULFONYLUREA RECEPTOR 2A; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL TISSUE; ARTICLE; CALCIUM CELL LEVEL; CALCIUM TRANSPORT; CELL STRAIN HEK293; CONCENTRATION RESPONSE; CONTROLLED STUDY; CORONARY ARTERY CONSTRICTION; DRUG STRUCTURE; EXTRASYSTOLE; GUINEA PIG; HEART CONTRACTION; HEART MUSCLE EXCITABILITY; HEART MUSCLE ISCHEMIA; HEART PROTECTION; HETEROLOGOUS EXPRESSION; HUMAN; HUMAN CELL; HYPERPOLARIZATION; LIPOPHILICITY; MALE; MEMBRANE CURRENT; NEWBORN; NONHUMAN; PRIORITY JOURNAL; RAT;

ANIMALS; CARDIOTONIC AGENTS; CELLS, CULTURED; FLUORINE; GLYBURIDE; GUINEA PIGS; HEART; HEK293 CELLS; HUMANS; KATP CHANNELS; MALE; MEMBRANE POTENTIALS; MEMBRANE TRANSPORT MODULATORS; MYOCARDIUM; MYOCYTES, CARDIAC; PATCH-CLAMP TECHNIQUES; PINACIDIL; RATS; REPERFUSION INJURY; SARCOLEMMA;

EID: 78651429284     PISSN: 00071188     EISSN: 14765381     Source Type: Journal    
DOI: 10.1111/j.1476-5381.2010.01072.x     Document Type: Article

References (23)

1. Alexander SPH, Mathie A, Peters JA, (2009). Guide to Receptors and Channels (GRAC), 4th edn. Br J Pharmacol 158 (Suppl. 1): S1-S254.
2. Begue J-P, Bonnet-Delpon D, (2008). Effects of fluorine substitution on biological properties. In:, Begue J-P, Bonnet-Delpon D, (eds). Bioorganic and Medicinal Chemistry of Fluorine. John Wiley & Sons, Inc.: Hoboken, New Jersey, pp. 72-98.
3. ATP channels to protect the ischemic myocardium: clinical implications. Exp Clin Cardiol 4: 20-22.
4. Charnock JS, (1999). Omega-3 polyunsaturated fatty acids and ventricular fibrillation: the possible involvement of eicosanoids. Prostaglandins Leukot Essent Fatty Acids 61: 243-247.
5. Cui Y, Giblin JP, Clapp LH, Tinker A, (2001). A mechanism for ATP-sensitive potassium channel diversity: functional coassembly of two pore-forming subunits. Proc Natl Acad Sci USA 98: 729-734.
6. ATP channel therapeutics at the bedside. J Mol Cell Cardiol 39: 99-112.
7. Kane GC, Liu XK, Yamada S, Olson TM, Terzic A, (2005). Cardiac KATP channels in health and disease. J Mol Cell Cardiol 38: 937-943.
8. Lymarenko IV, (2005). The comparative study of the effect of new fluorine-containing guanidine-derivate compounds and pinacidil on contractile function of the urinary bladder in vitro. Fiziol Zh [Ukrainian] 51: 88-91.
9. Misra MK, Sarwat M, Bhakuni P, Tuteja R, Tuteja N, (2009). Oxidative stress and ischemic myocardial syndromes. Med Sci Monit 15: RA209-RA219.
10. Moibenko AA, Strutynskyi RB, Yagupolskii LM, Mohort NA, (2009). Organization of industrial production of flocalin-new myotropic spasmolytic and cardioprotector. Sci Innov [Ukrainian] 1: 80-84.
11. Noma A, (1983). ATP-regulated K+ channels in cardiac muscle. Nature 305: 147-148.
12. Rogers TB, Gaa ST, Allen IS, (1986). Identification and characterization of functional angiotensin II receptors on cultured heart myocytes. J Pharmacol Exp Ther 236: 438-444.
13. Shaklai M, Tavassoli M, (1982). Lanthanum as an electron microscopic stain. J Histochem Cytochem 30: 1325-1330.
14. Shindo T, Yamada M, Isomoto S, Horio Y, Kurachi Y, (1998). SUR2 subtype (A and B)-dependent differential activation of the cloned ATP-sensitive K+ channels by pinacidil and nicorandil. Br J Pharmacol 124: 985-991.
15. Steinberg MI, Ertel P, Smallwood JK, Wyss V, Zimmerman K, (1988). The relation between vascular relaxant and cardiac electrophysiological effects of pinacidil. J Cardiovasc Pharmacol 12: S30-S40.
16. ATP channel activity in normotensive and hypertensive animals. Fiziol Zh [Ukrainian] 46: 54-60.
17. Strutyns'kyi RB, Moibenko OO, Iahupol's'kyi LM, (2000). The vasomotor effects of new fluorine-containing synthetic activators of ATP-dependent potassium channels. Fiziol Zh [Ukrainian] 46: 17-23.
18. Strutyns'kyi RB, Pyvovar SM, Tumanovska LV, Moibenko OO, (2008). Cardioprotective effects of flokalin: relative role of activation of sarcolemmal and mitochondrial adenosine triphosphate-dependent potassium channels. Fiziol Zh [Ukrainian] 54: 15-23.
19. Strutyns'kyi RB, Kotsiuruba AV, Neshcheret AP, Shysh AN, Rovenets RA, Moibenko AA, (2009a). Cardioprotective effects of flokalin in experiments in vivo: influence on biochemical parameters of blood at ischemia-reperfusion of a myocardium. Fiziol Zh [Ukrainian] 55: 12-19.
20. Strutyns'kyi RB, Neshcheret AP, Tumanovs'ka LV, Rovenets RA, Moibenko AA, (2009b). Cardioprotective effects of flokalin in experiments in vivo: influence on hemodynamic and damage of a myocardium at its ischemia-reperfusion. Fiziol Zh [Ukrainian] 55: 9-16.
21. Yagupolskii LM, Maletina II, Shavaran SS, Petko KI, Klebanov BM, (1997). N-1,2,2-trimethylpropyl-N'-cyano-N''-arylguanidines with fluorine containing substitutes in aromatic ring that have the hypotensive and cardiotonic action. Patent of Ukraine 17071.
22. Yagupolskii LM, Maletina II, Petko KI, Fedyuk DV, Handrock R, Shavaran SS, et al. (2001). New fluorine-containing hypotensive preparations. J Fluor Chem 109: 87-94.
23. Yamazaki T, Taguchi T, Iwao Ojima I, (2009). Unique properties of fluorine and their relevance to medicinal chemistry and chemical biology. In:, Ojima I, (ed.). Fluorine in Medicinal Chemistry and Chemical Biology. John Wiley & Sons, Inc.: West Sussex, UK, pp. 3-46.